Products Affected - Description
Precedex Injection in 0.9% Sodium Chloride, Hospira
4 mcg/mL, 100 mL premix glass bottle, 10 count (NDC 00409-1660-10)
4 mcg/mL, 50 mL premix glass bottle, 20 count (NDC 00409-1660-50)
Reason for the Shortage
- Hospira states the reason for the shortage is manufacturing delay.
- There are no other manufacturers of dexmedetomidine injection.
Precedex Injection, Hospira
100 mcg/mL, 2 mL single dose vial, 25 count (NDC 00409-1638-02)
Estimated Resupply Dates
Hospira has Precedex 50 mL and 100 mL premixed bottles on market reserve and the company estimates a release date of 4th quarter 2014 once this supply is depleted.
May 30, 2014; April 23, 2014; April 14, 2014, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins